• <em>In Vitro</em> Maturation of Oocytes Obtained from Ovarian Cortex Among Postpubertal Hematological Cancer Patients Undergoing Fertility Preservation
• "Off-The-Shelf" allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges
• A case of B-cell acute lymphoblastic lymphoma/leukemia with optic nerve involvement as first manifestation and detected by (18)F-FDG PET/CT
• A case of Ph(+) acute lymphoblastic leukemia and EGFR mutant lung adenocarcinoma synchronous overlap: may one TKI drug solve two diseases?
• A case of t-cell lymphoblastic lymphoma characterized by pleural effusion combined with pericardial effusion
• A new frontier in the battle against infant acute lymphoblastic leukemia
• ActivinA modulates B-acute lymphoblastic leukaemia cell communication and survival by inducing extracellular vesicles production
• Advancements in the Regulatory Role of microRNAs in Childhood Acute Lymphoblastic Leukemia: Mechanisms and Clinical Implications
• An attention-based deep learning for acute lymphoblastic leukemia classification
• An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia
• An unusual presentation of superior vena cava syndrome
• Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
• Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia
• Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
• Campylobacter jejuni bacteremia in a leukemic child: a nearly missed diagnosis
• Can we cure Ph+ ALL without chemotherapy or transplant?
• Cancer Statistics from the Shaukat Khanum Memorial Trust's Hospital-based Cancer Registry, Pakistan, 1994-2022: An Observational Study
• Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence
• Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia
• CDC27 gene expression patterns as a potential biomarker in Acute Leukemia
• Childhood cancer presentation and initial outcomes in Ethiopia: Findings from a recently opened pediatric oncology unit
• Childhood leukemia prevention within reach
• Clinical characteristics and prognosis of childhood acute lymphoblastic leukemia with CD123 expression
• Clonal Hematopoiesis Without Malignant Transformation Lasting Over 2 Years in a 9-Year-old Boy, Following Treatment for Acute Lymphocytic Leukemia
• Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
• Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38
• CRLF2 and IKZF1 abnormalities in childhood hematological malignancies other than B-cell Acute Lymphoblastic Leukemia
• Current situation and prospect of diagnosis and therapy of childhood acute leukemia in China
• Current state and future prospects of off-the-shelf allogeneic CAR NK therapy
• Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes
• Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
• Diagnostic value of procalcitonin in infections in patients with malignant hematologic diseases
• Difficult Removal of a Stuck Chemoport Catheter of a Paediatric Patient in Post-Coronavirus Disease (COVID-19) Era - Management Strategies and Literature Review
• Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
• Dysuria and Vaginal Pain, Unusual Manifestations of B-acute Lymphoblastic Lymphoma
• Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia
• Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
• Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword
• ETS1 Function in Leukemia and Lymphoma
• Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed-methods study protocol
• Exploring the potential of IL-10 for risk assessment and early intervention in pediatric ALL
• FDG altered biodistribution in white adipose tissue, a rare entity: case report and review of the literature
• Genetic evidence for predisposition to acute leukemias due to a missense mutation (p.Ser518Arg) in ZAP70 kinase: a case-control study
• Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review
• HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia
• Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
• Identification of Risk Factors for Relapse in Childhood Leukemia Using Penalized Semi-parametric Mixture Cure Competing Risks Model
• Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies
• Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic Leukemia
• Increased AID results in mutations at the CRLF2 locus implicated in Latin American ALL health disparities
• Late Adverse Effects after Treatment for Childhood Acute Leukemia
• Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
• Long-term efficacy and prognostic factors of Beijing Children's Hospital-2009-lymphoblastic lymphoma in the treatment of T-lymphoblastic lymphoma in children and adolescents
• Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature
• Long-Term Remission in T315I+ Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Blinatumomab and Allogeneic Stem Cell Transplantation: Two Case Studies
• Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies
• Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing
• Molecular Mechanism of circVRK1 Regulating the Proliferation and Apoptosis of Acute Lymphoblastic Leukemia KOCL44 Cells by Targeting miR-4428
• Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review
• New insight into the CNC-bZIP member, NFE2L3, in human diseases
• No evidence on infectious DNA-based agents in pediatric acute lymphoblastic leukemia using whole metagenome shotgun sequencing
• Nutritional Status and Body Composition at Diagnosis, of South Indian Children with Acute Lymphoblastic Leukaemia (ALL)
• Olverembatinib combined with inotuzumab ozogamicin in relapsed refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report
• Outcomes of children treated for relapsed or refractory acute lymphoblastic leukemia: A single tertiary care center experience
• Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study
• Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome
• Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype
• Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report
• Pituitary lymphoma appearing 9 years after pituitary adenoma resection
• Predictive model for CAR-T cell therapy success in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia
• Primary lymphoblastic B-cell lymphoma of the stomach in a 14-year-old Sudanese female; a case report
• RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia
• Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review
• Rhinocerebral mucormycosis and Trichosporon asahii fungemia in a pediatric patient with acute lymphoblastic leukemia: a rare coinfection
• Risk factors for recurrence of childhood acute lymphoblastic leukemia after treatment with the Chinese Children's Cancer Group ALL-2015 protocol
• Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia
• Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
• Severe capsular contracture in a patient with a history of multiple malignancies - Hematoma or neoplasm recurrence?: A case report
• Simultaneous Presentation of B-Acute Lymphoblastic Leukemia and Streptococcus agalactiae Meningitis in a 3-Year-old Girl
• Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort
• Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis
• Survival Status and Predictors of Mortality Among Children Admitted With Acute Lymphocytic Leukemia at Cancer Treatment Hospitals in Addis Ababa, Ethiopia
• Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population-based study in Sweden, Finland, and Denmark
• Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP
• Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia
• The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
• The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers
• The Molecular and Biological Function of MEF2D in Leukemia
• The Role of PTEN in Chemoresistance Mediated by the HIF-1alpha/YY1 Axis in Pediatric Acute Lymphoblastic Leukemia
• The Role of the JAK-STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia
• The safety and efficacy of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia in children
• The value of radiomics features of the spleen as surrogates for differentiating subtypes of common pediatric lymphomas
• TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
• TLR Agonists Modify NK Cell Activation and Increase Its Cytotoxicity in Acute Lymphoblastic Leukemia
• Treatment and outcomes of patients with B-ALL relapse after CD19 CAR-T therapy
• Tumor-Suppressive Cross-Linking of Anti-T. cruzi Antibodies in Acute Lymphoblastic Leukemia
• Unraveling Copy Number Alterations in Pediatric B-Cell Acute Lymphoblastic Leukemia: Correlation with Induction Phase Remission Using MLPA
• Upregulation of the long noncoding RNA GJA9-MYCBP and PVT1 is a potential diagnostic biomarker for acute lymphoblastic leukemia
• Utilization of Discharge Checklist and Improved Education Reduces Hospital Readmission Rates in Childhood Leukemia Patients Receiving Induction Therapy
• Utilizing Deep Feature Fusion for Automatic Leukemia Classification: An Internet of Medical Things-Enabled Deep Learning Framework